Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02840409
Title Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Hospital for Sick Children
Indications

high grade glioma

Therapies

Vinblastine

Bevacizumab + Vinblastine

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.